Samura, B.B. 2019. “Influence of Atorvastatin Therapy on Biological Markers and Cardiovascular Risk in Patients With Chronic Lymphocytic Leukemia in Remission”. Zaporozhye Medical Journal, no. 1 (February). https://doi.org/10.14739/2310-1210.2019.1.155793.